Alicia PhD

Alicia PhD
Location
New Hampshire, United States
Birthday
September 08
Bio
Alicia has a PhD in Experimental Pathology and, after having worked in a genetics lab for her dissertation, now edits scientific manuscripts full-time from the comfort of the White Mountains. Alicia is also a writer, contributing health commentary and articles on disease and anatomy to many online publishers. She upkeeps a number of blogs devoted to her interests in public health and science.

MY RECENT POSTS

SEPTEMBER 4, 2010 1:03AM

Where post-marketing safety goes to die

Rate: 2 Flag

You have probably read it or heard it when a controversial drug hits the market - "they were approved but require postmarketing safety studies". And then you don't hear about the drug for awhile, until it either gets surpassed by a competitor or kills someone.

Well, the FDA does require postmarketing studies and reporting, and they make the results and warnings provided by them available to the public. Where? you might ask...well I ran across one such page today and wanted to share. 

It's here.

And look at all those red asterisks. The list is of drugs with ongoing safety monitoring (could be completely innocent, for good measure, or not). The asterisks? Those are drugs with safety alerts. That page is your door to knowing which FDA-approved drugs have safety issues.

Some of it is old - from 2005 - but it is interesting to say the least.

Author tags:

drug safety, fda

Your tags:

TIP:

Enter the amount, and click "Tip" to submit!
Recipient's email address:
Personal message (optional):

Your email address:

Comments

Type your comment below:
Thanks for this, Alicia. Great resource when I'm preparing my Drug Design and Clinical Trials lecture.